OQROGet OQRO Pro
Politician trade (Senate)

Boston Scientific (BSX)Sen. John Boozman disclosed a partial sale $1K–$15K

Sen. John Boozman disclosed a partial sale of Boston Scientific in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
39 days
Disclosure lag
Traded
Jun 4, 2026
Disclosed
Jul 13, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 4, 2025Federal contract · $601K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $601K obligated to date
  2. Dec 23, 2025Federal contract · $493K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $493K obligated to date
  3. Mar 27, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  4. Apr 22, 2026Company filing · Form 8-K · ResultsReported its results
  5. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  6. Apr 30, 2026Company filing · Form 8-K · Bylaws or charter, Shareholder voteChanged its bylaws, charter or fiscal year, and held a shareholder vote
  7. May 6, 20265% stakeFMR LLC reported a passive stake (13G) of 5.1%
  8. May 11, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  9. May 19, 2026Insider · First insider buy since Dec 2024Director purchased ~$125K of BSX shares in the open market
  10. May 19, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  11. May 20, 2026Insider · 3 peopleInsiders: 3 purchases (~$429K)
  12. May 29, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
  13. Jun 4, 2026 · this disclosureCongressDisclosed partial sale of BSX — reported range $1,001 - $15,000

What came next

  1. Jun 5, 2026Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  2. Jul 14, 2026FDARecall: Suture Cinch Long 1pk. Endoscopic tissue approximation device.
  3. Jul 16, 2026Federal contract · $608K obligatedDepartment of Veterans Affairs awarded Boston Scientific: $608K obligated to date
  4. Jul 21, 2026Company filing · Form 8-K · RestructuringAnnounced job cuts, closures or a restructuring“On July 21, 2026, the Board of Directors of Boston Scientific Corporation (the “Company”) approved a new global restructuring program (the “2026 Restructuring Plan”).”
  5. Jul 22, 2026FDARecall: Boston Scientific Corporation StoneSmart Connect Console Contents: (1) Power Cord, (1) Power Adaptor, (1)DVI Cable, (1) DVI to HDMI Cable, (1) DisplayPort Cabl…
  6. Jul 24, 2026FDAFDA device clearance: TheraSphere 360™ Y-90 Management Platform
  7. Jul 24, 2026FDAFDA device clearance: OBSIDIO Conformable Embolic
  8. Jul 24, 2026FDAFDA device clearance: FARADRIVE™ Steerable Sheath (M004PF21M402)
  9. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
  10. Jul 31, 2026InsiderDirector purchased ~$227K of BSX shares in the open market
  11. Aug 3, 2026Insider · 2 peopleInsiders: 2 purchases (~$9.1M)
  12. Aug 4, 2026FDAFDA device clearance: Navigator™ Flex Ureteral Access Sheath Set
  13. Aug 4, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$6.8K of BSX shares in the open market
  14. Aug 5, 2026Insider · 3 insiders in a week, 7th time since 2006Director purchased ~$100K of BSX shares in the open market
  15. Aug 6, 2026FDARecall: LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS US, Model Number 7260, All Versions (Current 7.8)
  16. Aug 6, 2026FDARecall: LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS ANZ, Model Number 7248, All Versions (Current 7.7)
  17. Aug 6, 2026FDARecall: LUX-Dx, LUX-Dx II, LUX-Dx II+ Insertable Cardiac Monitor System, SERVER SW LAT CLARITY DS EU, Model Number 7246, All Versions (Current 7.7)
  18. Aug 6, 20265% stakeFMR LLC reported a passive stake (13G) of 3.1%
  19. Aug 12, 2026FDAFDA device clearance: EluPro Antibiotic-Eluting BioEnvelope
  20. Aug 18, 2026CongressDisclosed purchase of BSX — reported range $1,001 - $15,000
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Boston Scientific

For Boston Scientific, OQRO holds 6 insider filings (SEC Form 4 or Form 144), 9 Congress trade reports, 64 fund holdings reports (13F) and 8 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its BSX page.

Other recent filings by Sen. John Boozman

The full history of Sen. John Boozman is on the profile page.

How this filing works

Other disclosures at Boston Scientific

Everything OQRO holds on this company is on its BSX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data